0
     

Report Added
Report already added
Regenerative Medicines: Bone and Joint Applications

Regenerative Medicines: Bone and Joint Applications

Report Scope:

The report explains critical trends in the regenerative medicine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.

This study looks at most of the systems affected by factors such as R&D spending and increasing competition and new technologies.

This report also covers merger and acquisition strategies and collaborations, as well as the strengths and weaknesses of each strategy type.

The market has also been analyzed based on regenerative medicine for bone and joint applications. Categories considered in this report include allogeneic bones, autogenic bones, bone graft substitutes, osteoarticular diseases and others.

The report provides information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.

Report Includes:

- 51 tables
- An overview of the global market for regenerative medicines for bone and joint applications
- Estimation of the market size and analyses of global market trends, with data from 2020 to 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
- Characterization and quantification of market potential for regenerative medicines by technology, application, and region
- Coverage and discussion on regulatory delays due to COVID-19, clinical trials and product launches of the industry
- Description of principle approaches to regenerative medicine and discussion on importance of scaffolding in tissue engineering
- Information on major drivers and regional dynamics of the market and current trends within the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies
- Company profiles of major players, including Anika Therapeutics, Conmed Corp., Johnson & Johnson and Stryker Corp.
Table of Contents

Chapter 1 Introduction
Background
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Overview of Regenerative Medicine
How Regenerative Medicine Works
Principal Approaches to Regenerative Medicine
Cells and Tissues
Tissue Engineering
Importance of Scaffolding in Tissue Engineering
Plastic Scaffolding
Blood Vessel Scaffolding
Center for Integration of Medicine and Innovative Technology (CIMIT)
Embryonic Stem Cells
Chapter 4 Impact of COVID-19
Overview
Impact of COVID-19 on Cell and Gene Therapies, and Regenerative Medicine for Bone and Joint Applications
Direct Impact on Clinical Trials in Cell and Gene Therapy
Chapter 5 Market Dynamics
Market Drivers
Rising Number of Bone and Joint Disorders and Orthopedic Surgeries
Increasing Product Approvals and Launches
R&D for Stem and Gene Therapies
Market Restraints
Stringent Government Regulatory Settings in R&D
Market Opportunities
Growing Pipeline for Regenerative Medicines
Competitive Landscape
Chapter 6 Market Breakdown by Technology
Global Market by Technology
Biomaterials
Biomaterials for Regeneration
Market Size and Forecast
Stem Cell Therapy
Market Size and Forecast
Tissue Engineering
Market Size and Forecast
Chapter 7 Market Breakdown by Application
Global Market by Application
Allogeneic Bones
Market Size and Forecast
Autogenic Bones
Market Size and Forecast
Bone Graft Substitutes
Market Size and Forecast
Osteoarticular Diseases
Market Size and Forecast
Other Diseases
Market Size and Forecast
Chapter 8 Market Breakdown by Region
Global Market by Region
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
Australia
India
Rest of Asia-Pacific
Rest of the World
Chapter 9 Company Profiles
ANIKA THERAPEUTICS INC.
ARTHREX INC.
BAXTER INTERNATIONAL INC.
BIOVENTUS
CONMED CORP.
DEPUY SYNTHES PRODUCTS INC. (PART OF JOHNSON & JOHNSON)
MEDTRONIC PLC
SEIKAGAKU CORP.
SMITH & NEPHEW PLC
STRYKER CORP.
ZIMMER BIOMET HOLDINGS INC.
Chapter 10 Appendix: List of Acronyms

List of Tables
Summary Table : Global Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table A : Comparison of Changes in the Segmentation of Previous and Current Version of Report
Table 1 : Top Three Companies in the Global Market for Regenerative Medicine for Bone and Joint Applications, 2021
Table 2 : Global Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 3 : Biomaterial-Assisted Gene Therapy in Musculoskeletal Research
Table 4 : Global Market for Biomaterials in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 5 : Global Market for Stem Cell Therapy in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 6 : Biomaterials Utilized for Specific Target Tissues and Cell Types
Table 7 : Global Market for Tissue Engineering in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 8 : Global Market for Regenerative Medicine for Bone and Joint Applications, by Application, Through 2027
Table 9 : Global Market for Allogeneic Bones in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 10 : Global Market for Autogenic Bones in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 11 : Global Market for Bone Graft Substitutes in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 12 : Global Market for Osteoarticular Diseases in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 13 : Global Market for Other Disease Applications in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 14 : Global Regenerative Medicine Market for Bone and Joint Applications, by Region, Through 2027
Table 15 : North American Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 16 : North American Market for Regenerative Medicine for Bone and Joint Applications, by Country, Through 2027
Table 17 : European Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 18 : European Market for Regenerative Medicine for Bone and Joint Applications, by Country, Through 2027
Table 19 : Asia-Pacific Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 20 : Asia-Pacific Market for Regenerative Medicine for Bone and Joint Applications, by Country, Through 2027
Table 21 : Rest of the World Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 22 : Anika Therapeutics: R&D Expenditures, 2019-2021
Table 23 : Anika Therapeutics: Products Offered
Table 24 : Anika Therapeutics: Recent Developments
Table 25 : Arthrex Inc.: Products Offered
Table 26 : Arthrex Inc.: Recent Developments
Table 27 : Baxter International: Products Offered
Table 28 : Bioventus: Products Offered
Table 29 : Bioventus: Recent Developments
Table 30 : Conmed Corp.: R&D Expenditures, 2019-2021
Table 31 : Conmed Corp.: Products Offered
Table 32 : Conmed Corp.: Recent Developments
Table 33 : Johnson & Johnson (DePuy Synthes Companies): R&D Expenditures, 2019-2021
Table 34 : Johnson & Johnson (DePuy Synthes Companies): Products Offered
Table 35 : Johnson & Johnson (DePuy Synthes Companies): Recent Developments
Table 36 : Medtronic PLC: R&D Expenditures, 2019-2021
Table 37 : Medtronic PLC: Products Offered
Table 38 : Medtronic PLC: Recent Developments
Table 39 : Seikagaku Corp.: Products Offered
Table 40 : Seikagaku Corp.: Recent Developments
Table 41 : Smith & Nephew: R&D Expenditures, 2019-2021
Table 42 : Smith & Nephew: Products Offered
Table 43 : Smith & Nephew: Recent Developments
Table 44 : Stryker Corp.: R&D Expenditures, 2019-2021
Table 45 : Stryker Corp.: Products Offered
Table 46 : Stryker Corp.: Recent Developments
Table 47 : Zimmer Biomet Holdings: R&D Expenditures, 2018-2020
Table 48 : Zimmer Biomet Holdings: Products Offered
Table 49 : Zimmer Biomet Holdings: Recent Developments
Table 50 : Acronyms Used in This Report

Report Title: Regenerative Medicines: Bone and Joint Applications


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW